1,911
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Update on respiratory syncytial virus hospitalizations among U.S. preterm and term infants before and after the 2014 American Academy of Pediatrics policy on immunoprophylaxis: 2011-2017

, , , ORCID Icon, &
Pages 1536-1545 | Received 22 May 2020, Accepted 04 Sep 2020, Published online: 22 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Elizabeth R. Packnett, Isabelle H. Winer, Abiola Oladapo & Matthew Wojdyla. (2023) Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29–34 wGA) infants without outpatient palivizumab administration. Human Vaccines & Immunotherapeutics 19:2.
Read now
Elizabeth R. Packnett, Isabelle H. Winer, Heather Larkin, Abiola Oladapo, Tara Gonzales, Matthew Wojdyla, Mitchell Goldstein & Vincent C. Smith. (2022) RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020. Human Vaccines & Immunotherapeutics 18:6.
Read now

Articles from other publishers (10)

Amanda M. Kong, Isabelle H. Winer, Nicole M. Zimmerman, David Diakun, Adam Bloomfield, Tara Gonzales, Jaime Fergie, Mitchell Goldstein & Leonard R. Krilov. (2021) Increasing Rates of RSV Hospitalization among Preterm Infants: A Decade of Data. American Journal of Perinatology 40:14, pages 1529-1536.
Crossref
Mary T. Caserta, Sean T. O’Leary, Flor M. Munoz, Shawn L. Ralston, Sean T. O’Leary, James D. Campbell, Monica I. Ardura, Ritu Banerjee, Kristina A. Bryant, Mary T. Caserta, Jeffrey S. Gerber, Chandy C. John, Athena P. Kourtis, Angela Myers, Pia Pannaraj, Adam J. Ratner, José R. Romero, Samir S. Shah, Kenneth M. Zangwill, Yvonne A. Maldonado, Flor M. Munoz, Shawn L. Ralston, David W. Kimberlin, Elizabeth D. Barnett, Ruth Lynfield, Mark H. Sawyer, Henry H. Bernstein, Karen M. Farizo, Lisa M. Kafer, David Kim, Eduardo López Medina, Denee Moore, Lakshmi Panagiotakopoulos, Laura Sauvé, Jeffrey R. Starke, Jennifer Thompson, Kay M. Tomashek, Melinda Wharton, Charles R. WoodsJr.Jr. & Jennifer M. Frantz. (2023) Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics 152:1.
Crossref
Marcelo Comerlato Scotta & Renato Tetelbom Stein. (2023) Current strategies and perspectives for active and passive immunization against Respiratory Syncytial Virus in childhood. Jornal de Pediatria 99, pages S4-S11.
Crossref
Paolo Manzoni, Eugenio Baraldi, Manuel Sánchez Luna & Chryssoula Tzialla. (2022) Real-World Studies of Respiratory Syncytial Virus Hospitalizations among Moderate/Late Preterm Infants Exposed to Passive Immunoprophylaxis with Palivizumab. American Journal of Perinatology 39:S 01, pages S7-S13.
Crossref
Clara Galvis, Alejandro Colmenares, Lina Cabrales, Linda Ibatá, Juliana Marulanda, Oscar Ovalle, Dionisio Puello, Catherine Rojas, Martha Africano, Adriana Ballesteros & Héctor Posso. (2022) Impact of immunoprophylaxis with palivizumab on respiratory syncytial virus infection in preterm infants less than 35 weeks in Colombian hospitals. Pediatric Pulmonology 57:10, pages 2420-2427.
Crossref
Mina Suh, Naimisha Movva, Lauren C Bylsma, Jon P Fryzek & Christopher B Nelson. (2022) A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year. The Journal of Infectious Diseases 226:Supplement_2, pages S195-S212.
Crossref
Jason R Gantenberg, Robertus van Aalst, Nicole Zimmerman, Brendan Limone, Sandra S Chaves, William V La Via, Christopher B Nelson, Christopher Rizzo, David A Savitz & Andrew R Zullo. (2022) Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020. The Journal of Infectious Diseases 226:Supplement_2, pages S164-S174.
Crossref
Mitchell Goldstein, Benjamin Harding & Elba Fayard. (2021) Guidance for palivizumab prophylaxis and implications for compliance. Pediatric Pulmonology 56:12, pages 3575-3576.
Crossref
Jintanat Ananworanich & Penny M. Heaton. (2021) Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities. Vaccines 9:9, pages 961.
Crossref
Nour Mammari, Ysaline Krier, Quentin Albert, Marc Devocelle & Mihayl Varbanov. (2021) Plant-Derived Antimicrobial Peptides as Potential Antiviral Agents in Systemic Viral Infections. Pharmaceuticals 14:8, pages 774.
Crossref